Interactions between canthaxanthin and lipid membranes--possible mechanisms of canthaxanthin toxicity
- PMID: 19214394
- PMCID: PMC6275664
- DOI: 10.2478/s11658-009-0010-8
Interactions between canthaxanthin and lipid membranes--possible mechanisms of canthaxanthin toxicity
Abstract
Canthaxanthin (beta, beta-carotene 4, 4' dione) is used widely as a drug or as a food and cosmetic colorant, but it may have some undesirable effects on human health, mainly caused by the formation of crystals in the macula lutea membranes of the retina. This condition is called canthaxanthin retinopathy. It has been shown that this type of dysfunction of the eye is strongly connected with damage to the blood vessels around the place of crystal deposition. This paper is a review of the experimental data supporting the hypothesis that the interactions of canthaxanthin with the lipid membranes and the aggregation of this pigment may be the factors enhancing canthaxanthin toxicity towards the macula vascular system. All the results of the experiments that have been done on model systems such as monolayers of pure canthaxanthin and mixtures of canthaxanthin and lipids, oriented bilayers or liposomes indicate a very strong effect of canthaxanthin on the physical properties of lipid membranes, which may explain its toxic action, which leads to the further development of canthaxanthin retinopathy.
Similar articles
-
Exceptional molecular organization of canthaxanthin in lipid membranes.Acta Biochim Pol. 2012;59(1):31-3. Epub 2012 Mar 17. Acta Biochim Pol. 2012. PMID: 22428120 Review.
-
Studies on canthaxanthin in lipid membranes.Biochim Biophys Acta. 2005 Jun 15;1712(1):17-28. doi: 10.1016/j.bbamem.2005.03.010. Epub 2005 Apr 11. Biochim Biophys Acta. 2005. PMID: 15950595
-
Occurrence of birefringent retinal inclusions in cynomolgus monkeys after high doses of canthaxanthin.Invest Ophthalmol Vis Sci. 1997 Mar;38(3):741-52. Invest Ophthalmol Vis Sci. 1997. PMID: 9071228
-
[Canthaxanthin retinopathy and macular pucker].J Fr Ophtalmol. 1989;12(12):891-6. J Fr Ophtalmol. 1989. PMID: 2517961 French.
-
Model answers to lipid membrane questions.Cold Spring Harb Perspect Biol. 2011 Sep 1;3(9):a004622. doi: 10.1101/cshperspect.a004622. Cold Spring Harb Perspect Biol. 2011. PMID: 21610116 Free PMC article. Review.
Cited by 4 articles
-
Canthaxanthin, a Red-Hot Carotenoid: Applications, Synthesis, and Biosynthetic Evolution.Plants (Basel). 2020 Aug 15;9(8):1039. doi: 10.3390/plants9081039. Plants (Basel). 2020. PMID: 32824217 Free PMC article. Review.
-
Mitochondrion-Permeable Antioxidants to Treat ROS-Burst-Mediated Acute Diseases.Oxid Med Cell Longev. 2016;2016:6859523. doi: 10.1155/2016/6859523. Epub 2015 Nov 16. Oxid Med Cell Longev. 2016. PMID: 26649144 Free PMC article. Review.
-
Canthaxanthin retinopathy with visual loss: a case report and review.Case Rep Ophthalmol Med. 2013;2013:140901. doi: 10.1155/2013/140901. Epub 2013 Oct 30. Case Rep Ophthalmol Med. 2013. PMID: 24288637 Free PMC article.
-
Cellular membrane phospholipids act as a depository for quaternary amine containing drugs thus competing with the acetylcholine/nicotinic receptor.J Proteome Res. 2012 Jun 1;11(6):3382-9. doi: 10.1021/pr300184g. Epub 2012 Apr 30. J Proteome Res. 2012. PMID: 22506649 Free PMC article.
References
-
- Harnois C., Samson J., Malenfant M., Rousseau A. Canthaxanthin retinopathy. Anatomic and functional reversibility. Arch. Ophtalmol. 1989;107:538–540. - PubMed
-
- Bloomenstein M.R., Pinkert R.B. Canthaxanthine retinopathy. J. Am. Optom. Assoc. 1996;67:690–692. - PubMed
-
- McGuinnes R., Beaumont P. Gold dust retinopathy after the ingestion of canthaxanthin to produce skin-bronzing. Med. J. 1985;143:622–623. - PubMed
-
- White G.L.J., Beesley R., Thiese S.M., Murdock R.T. Retinal crystals and oral tanning agents. Am. Fam. Physician. 1988;37:125–126. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources